nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—kidney cancer	0.629	1	CbGaD
Ramipril—ACE—renal artery—kidney cancer	0.0287	0.376	CbGeAlD
Ramipril—ACE—nephron—kidney cancer	0.01	0.131	CbGeAlD
Ramipril—ACE—urine—kidney cancer	0.00804	0.105	CbGeAlD
Ramipril—SLC15A1—nephron tubule—kidney cancer	0.00302	0.0395	CbGeAlD
Ramipril—SLC15A1—renal system—kidney cancer	0.00274	0.0359	CbGeAlD
Ramipril—SLC15A1—kidney—kidney cancer	0.00265	0.0348	CbGeAlD
Ramipril—ACE—nephron tubule—kidney cancer	0.00216	0.0283	CbGeAlD
Ramipril—ACE—renal system—kidney cancer	0.00197	0.0258	CbGeAlD
Ramipril—ACE—kidney—kidney cancer	0.0019	0.0249	CbGeAlD
Ramipril—SLC15A2—nephron tubule—kidney cancer	0.00189	0.0247	CbGeAlD
Ramipril—ACE—cortex of kidney—kidney cancer	0.00185	0.0243	CbGeAlD
Ramipril—ACE—gonad—kidney cancer	0.00176	0.0231	CbGeAlD
Ramipril—ACE—cardiac atrium—kidney cancer	0.00176	0.0231	CbGeAlD
Ramipril—SLC15A2—renal system—kidney cancer	0.00172	0.0225	CbGeAlD
Ramipril—SLC15A2—kidney—kidney cancer	0.00166	0.0217	CbGeAlD
Ramipril—SLC15A2—cortex of kidney—kidney cancer	0.00162	0.0212	CbGeAlD
Ramipril—BCHE—nephron tubule—kidney cancer	0.0016	0.0209	CbGeAlD
Ramipril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.00141	0.126	CbGpPWpGaD
Ramipril—BCHE—cardiac atrium—kidney cancer	0.0013	0.017	CbGeAlD
Ramipril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.00103	0.0911	CbGpPWpGaD
Ramipril—Perindopril—BCHE—kidney cancer	0.00094	0.372	CrCbGaD
Ramipril—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.000757	0.0672	CbGpPWpGaD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—ACHE—kidney cancer	0.000414	0.0368	CbGpPWpGaD
Ramipril—BCHE—Synthesis of PC—ACHE—kidney cancer	0.000379	0.0337	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—MME—kidney cancer	0.000371	0.033	CbGpPWpGaD
Ramipril—Perindopril—ABCB1—kidney cancer	0.000368	0.146	CrCbGaD
Ramipril—Nateglinide—PTGS1—kidney cancer	0.000335	0.132	CrCbGaD
Ramipril—Cilazapril—ABCB1—kidney cancer	0.000325	0.128	CrCbGaD
Ramipril—Lisinopril—ABCB1—kidney cancer	0.000325	0.128	CrCbGaD
Ramipril—ACE—Peptide hormone metabolism—ACHE—kidney cancer	0.000285	0.0253	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—PAX6—kidney cancer	0.000271	0.0241	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—CTSD—kidney cancer	0.00027	0.0239	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—BCHE—kidney cancer	0.000248	0.022	CbGpPWpGaD
Ramipril—Enalapril—ABCB1—kidney cancer	0.000238	0.0942	CrCbGaD
Ramipril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000238	0.0211	CbGpPWpGaD
Ramipril—BCHE—Irinotecan Pathway—APC—kidney cancer	0.000229	0.0203	CbGpPWpGaD
Ramipril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000221	0.0196	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—MME—kidney cancer	0.000149	0.0132	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—EIF5B—kidney cancer	0.000142	0.0126	CbGpPWpGaD
Ramipril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00014	0.0124	CbGpPWpGaD
Ramipril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00013	0.0115	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—POMC—kidney cancer	0.000128	0.0114	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CUL7—kidney cancer	0.000127	0.0112	CbGpPWpGaD
Ramipril—Immune system disorder—Capecitabine—kidney cancer	0.000121	0.000431	CcSEcCtD
Ramipril—Chest pain—Paclitaxel—kidney cancer	0.000121	0.000431	CcSEcCtD
Ramipril—Arthralgia—Paclitaxel—kidney cancer	0.000121	0.000431	CcSEcCtD
Ramipril—Myalgia—Paclitaxel—kidney cancer	0.000121	0.000431	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—HSPA9—kidney cancer	0.000121	0.0107	CbGpPWpGaD
Ramipril—Mediastinal disorder—Capecitabine—kidney cancer	0.000121	0.00043	CcSEcCtD
Ramipril—Anxiety—Paclitaxel—kidney cancer	0.00012	0.000429	CcSEcCtD
Ramipril—Decreased appetite—Gemcitabine—kidney cancer	0.00012	0.000429	CcSEcCtD
Ramipril—Hypersensitivity—Dactinomycin—kidney cancer	0.00012	0.000429	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00012	0.000428	CcSEcCtD
Ramipril—Arrhythmia—Capecitabine—kidney cancer	0.00012	0.000426	CcSEcCtD
Ramipril—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000119	0.000426	CcSEcCtD
Ramipril—Discomfort—Paclitaxel—kidney cancer	0.000119	0.000426	CcSEcCtD
Ramipril—Fatigue—Gemcitabine—kidney cancer	0.000119	0.000425	CcSEcCtD
Ramipril—Gastrointestinal pain—Vincristine—kidney cancer	0.000119	0.000425	CcSEcCtD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000119	0.0105	CbGpPWpGaD
Ramipril—Dizziness—Sorafenib—kidney cancer	0.000119	0.000422	CcSEcCtD
Ramipril—Constipation—Gemcitabine—kidney cancer	0.000118	0.000422	CcSEcCtD
Ramipril—Nausea—Erlotinib—kidney cancer	0.000118	0.000422	CcSEcCtD
Ramipril—Alopecia—Capecitabine—kidney cancer	0.000118	0.000421	CcSEcCtD
Ramipril—Dry mouth—Paclitaxel—kidney cancer	0.000118	0.000421	CcSEcCtD
Ramipril—Diarrhoea—Sunitinib—kidney cancer	0.000118	0.00042	CcSEcCtD
Ramipril—Mental disorder—Capecitabine—kidney cancer	0.000117	0.000418	CcSEcCtD
Ramipril—Asthenia—Dactinomycin—kidney cancer	0.000117	0.000417	CcSEcCtD
Ramipril—Confusional state—Paclitaxel—kidney cancer	0.000117	0.000416	CcSEcCtD
Ramipril—Blood creatinine increased—Doxorubicin—kidney cancer	0.000117	0.000416	CcSEcCtD
Ramipril—Malnutrition—Capecitabine—kidney cancer	0.000116	0.000415	CcSEcCtD
Ramipril—Erythema—Capecitabine—kidney cancer	0.000116	0.000415	CcSEcCtD
Ramipril—Oedema—Paclitaxel—kidney cancer	0.000116	0.000413	CcSEcCtD
Ramipril—Anaphylactic shock—Paclitaxel—kidney cancer	0.000116	0.000413	CcSEcCtD
Ramipril—Abdominal pain—Vincristine—kidney cancer	0.000115	0.000411	CcSEcCtD
Ramipril—Body temperature increased—Vincristine—kidney cancer	0.000115	0.000411	CcSEcCtD
Ramipril—Liver function test abnormal—Doxorubicin—kidney cancer	0.000115	0.00041	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—ACHE—kidney cancer	0.000114	0.0102	CbGpPWpGaD
Ramipril—Dysgeusia—Capecitabine—kidney cancer	0.000114	0.000407	CcSEcCtD
Ramipril—Dizziness—Sunitinib—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Feeling abnormal—Gemcitabine—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Shock—Paclitaxel—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Vomiting—Sorafenib—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Abdominal pain upper—Doxorubicin—kidney cancer	0.000114	0.000406	CcSEcCtD
Ramipril—Nervous system disorder—Paclitaxel—kidney cancer	0.000114	0.000405	CcSEcCtD
Ramipril—Thrombocytopenia—Paclitaxel—kidney cancer	0.000113	0.000404	CcSEcCtD
Ramipril—Tachycardia—Paclitaxel—kidney cancer	0.000113	0.000403	CcSEcCtD
Ramipril—Rash—Sorafenib—kidney cancer	0.000113	0.000403	CcSEcCtD
Ramipril—Dermatitis—Sorafenib—kidney cancer	0.000113	0.000402	CcSEcCtD
Ramipril—Breast disorder—Doxorubicin—kidney cancer	0.000113	0.000402	CcSEcCtD
Ramipril—Skin disorder—Paclitaxel—kidney cancer	0.000113	0.000401	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000112	0.0004	CcSEcCtD
Ramipril—Headache—Sorafenib—kidney cancer	0.000112	0.0004	CcSEcCtD
Ramipril—Muscle spasms—Capecitabine—kidney cancer	0.000112	0.000399	CcSEcCtD
Ramipril—Hyperhidrosis—Paclitaxel—kidney cancer	0.000112	0.000399	CcSEcCtD
Ramipril—Diarrhoea—Dactinomycin—kidney cancer	0.000112	0.000398	CcSEcCtD
Ramipril—BCHE—Glycerophospholipid biosynthesis—ACHE—kidney cancer	0.000111	0.00987	CbGpPWpGaD
Ramipril—Anorexia—Paclitaxel—kidney cancer	0.00011	0.000394	CcSEcCtD
Ramipril—Gastritis—Doxorubicin—kidney cancer	0.00011	0.000393	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00011	0.00977	CbGpPWpGaD
Ramipril—Vomiting—Sunitinib—kidney cancer	0.00011	0.000391	CcSEcCtD
Ramipril—Body temperature increased—Gemcitabine—kidney cancer	0.000109	0.00039	CcSEcCtD
Ramipril—Tremor—Capecitabine—kidney cancer	0.000109	0.000389	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—PAX6—kidney cancer	0.000109	0.00966	CbGpPWpGaD
Ramipril—Rash—Sunitinib—kidney cancer	0.000109	0.000387	CcSEcCtD
Ramipril—Dermatitis—Sunitinib—kidney cancer	0.000109	0.000387	CcSEcCtD
Ramipril—Hypotension—Paclitaxel—kidney cancer	0.000108	0.000386	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—CTSD—kidney cancer	0.000108	0.00961	CbGpPWpGaD
Ramipril—Ill-defined disorder—Capecitabine—kidney cancer	0.000108	0.000385	CcSEcCtD
Ramipril—Headache—Sunitinib—kidney cancer	0.000108	0.000385	CcSEcCtD
Ramipril—Dysphagia—Doxorubicin—kidney cancer	0.000108	0.000384	CcSEcCtD
Ramipril—Influenza—Doxorubicin—kidney cancer	0.000108	0.000384	CcSEcCtD
Ramipril—Asthma—Doxorubicin—kidney cancer	0.000108	0.000384	CcSEcCtD
Ramipril—Hypersensitivity—Vincristine—kidney cancer	0.000107	0.000383	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—kidney cancer	0.000107	0.00038	CcSEcCtD
Ramipril—Nausea—Sorafenib—kidney cancer	0.000106	0.000379	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—kidney cancer	0.000106	0.000377	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000106	0.000376	CcSEcCtD
Ramipril—Malaise—Capecitabine—kidney cancer	0.000105	0.000374	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—kidney cancer	0.000105	0.000374	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000105	0.00932	CbGpPWpGaD
Ramipril—Insomnia—Paclitaxel—kidney cancer	0.000105	0.000373	CcSEcCtD
Ramipril—Vertigo—Capecitabine—kidney cancer	0.000105	0.000373	CcSEcCtD
Ramipril—Asthenia—Vincristine—kidney cancer	0.000105	0.000373	CcSEcCtD
Ramipril—Syncope—Capecitabine—kidney cancer	0.000104	0.000372	CcSEcCtD
Ramipril—Leukopenia—Capecitabine—kidney cancer	0.000104	0.000372	CcSEcCtD
Ramipril—Paraesthesia—Paclitaxel—kidney cancer	0.000104	0.000371	CcSEcCtD
Ramipril—Vomiting—Dactinomycin—kidney cancer	0.000104	0.00037	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—kidney cancer	0.000104	0.000369	CcSEcCtD
Ramipril—Dyspnoea—Paclitaxel—kidney cancer	0.000103	0.000368	CcSEcCtD
Ramipril—Somnolence—Paclitaxel—kidney cancer	0.000103	0.000367	CcSEcCtD
Ramipril—Palpitations—Capecitabine—kidney cancer	0.000103	0.000367	CcSEcCtD
Ramipril—Rash—Dactinomycin—kidney cancer	0.000103	0.000367	CcSEcCtD
Ramipril—Nausea—Sunitinib—kidney cancer	0.000102	0.000365	CcSEcCtD
Ramipril—Loss of consciousness—Capecitabine—kidney cancer	0.000102	0.000365	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—kidney cancer	0.000102	0.000365	CcSEcCtD
Ramipril—Dyspepsia—Paclitaxel—kidney cancer	0.000102	0.000363	CcSEcCtD
Ramipril—Cough—Capecitabine—kidney cancer	0.000102	0.000362	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—kidney cancer	0.000101	0.000359	CcSEcCtD
Ramipril—Decreased appetite—Paclitaxel—kidney cancer	0.000101	0.000359	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.0001	0.000357	CcSEcCtD
Ramipril—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.0001	0.000356	CcSEcCtD
Ramipril—Fatigue—Paclitaxel—kidney cancer	9.99e-05	0.000356	CcSEcCtD
Ramipril—Diarrhoea—Vincristine—kidney cancer	9.98e-05	0.000356	CcSEcCtD
Ramipril—Asthenia—Gemcitabine—kidney cancer	9.93e-05	0.000354	CcSEcCtD
Ramipril—Arthralgia—Capecitabine—kidney cancer	9.92e-05	0.000353	CcSEcCtD
Ramipril—Myalgia—Capecitabine—kidney cancer	9.92e-05	0.000353	CcSEcCtD
Ramipril—Chest pain—Capecitabine—kidney cancer	9.92e-05	0.000353	CcSEcCtD
Ramipril—Constipation—Paclitaxel—kidney cancer	9.91e-05	0.000353	CcSEcCtD
Ramipril—Anxiety—Capecitabine—kidney cancer	9.88e-05	0.000352	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.85e-05	0.000351	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—MUC4—kidney cancer	9.84e-05	0.00874	CbGpPWpGaD
Ramipril—Photosensitivity reaction—Doxorubicin—kidney cancer	9.84e-05	0.000351	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—kidney cancer	9.81e-05	0.00035	CcSEcCtD
Ramipril—Discomfort—Capecitabine—kidney cancer	9.8e-05	0.000349	CcSEcCtD
Ramipril—Pruritus—Gemcitabine—kidney cancer	9.79e-05	0.000349	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—RYR1—kidney cancer	9.74e-05	0.00865	CbGpPWpGaD
Ramipril—Dry mouth—Capecitabine—kidney cancer	9.7e-05	0.000346	CcSEcCtD
Ramipril—Nausea—Dactinomycin—kidney cancer	9.7e-05	0.000346	CcSEcCtD
Ramipril—Dizziness—Vincristine—kidney cancer	9.65e-05	0.000344	CcSEcCtD
Ramipril—Confusional state—Capecitabine—kidney cancer	9.59e-05	0.000342	CcSEcCtD
Ramipril—Feeling abnormal—Paclitaxel—kidney cancer	9.55e-05	0.00034	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	9.53e-05	0.000339	CcSEcCtD
Ramipril—Oedema—Capecitabine—kidney cancer	9.51e-05	0.000339	CcSEcCtD
Ramipril—Gastrointestinal pain—Paclitaxel—kidney cancer	9.47e-05	0.000338	CcSEcCtD
Ramipril—Diarrhoea—Gemcitabine—kidney cancer	9.47e-05	0.000337	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—kidney cancer	9.45e-05	0.000337	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—kidney cancer	9.42e-05	0.000336	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—kidney cancer	9.37e-05	0.000334	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—kidney cancer	9.37e-05	0.000334	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	9.36e-05	0.00832	CbGpPWpGaD
Ramipril—Shock—Capecitabine—kidney cancer	9.35e-05	0.000333	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—kidney cancer	9.34e-05	0.000333	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—kidney cancer	9.34e-05	0.000333	CcSEcCtD
Ramipril—Nervous system disorder—Capecitabine—kidney cancer	9.32e-05	0.000332	CcSEcCtD
Ramipril—Thrombocytopenia—Capecitabine—kidney cancer	9.31e-05	0.000332	CcSEcCtD
Ramipril—Tachycardia—Capecitabine—kidney cancer	9.28e-05	0.000331	CcSEcCtD
Ramipril—Vomiting—Vincristine—kidney cancer	9.27e-05	0.00033	CcSEcCtD
Ramipril—Skin disorder—Capecitabine—kidney cancer	9.23e-05	0.000329	CcSEcCtD
Ramipril—Sweating—Doxorubicin—kidney cancer	9.21e-05	0.000328	CcSEcCtD
Ramipril—Urticaria—Paclitaxel—kidney cancer	9.2e-05	0.000328	CcSEcCtD
Ramipril—Rash—Vincristine—kidney cancer	9.2e-05	0.000328	CcSEcCtD
Ramipril—Hyperhidrosis—Capecitabine—kidney cancer	9.19e-05	0.000328	CcSEcCtD
Ramipril—Dermatitis—Vincristine—kidney cancer	9.19e-05	0.000327	CcSEcCtD
Ramipril—Body temperature increased—Paclitaxel—kidney cancer	9.16e-05	0.000326	CcSEcCtD
Ramipril—Abdominal pain—Paclitaxel—kidney cancer	9.16e-05	0.000326	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	9.15e-05	0.00813	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—EEF2—kidney cancer	9.15e-05	0.00813	CbGpPWpGaD
Ramipril—Headache—Vincristine—kidney cancer	9.14e-05	0.000326	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—kidney cancer	9.09e-05	0.000324	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—kidney cancer	9.06e-05	0.000323	CcSEcCtD
Ramipril—Anorexia—Capecitabine—kidney cancer	9.06e-05	0.000323	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—kidney cancer	9.02e-05	0.000321	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—kidney cancer	8.97e-05	0.00032	CcSEcCtD
Ramipril—Hypotension—Capecitabine—kidney cancer	8.88e-05	0.000317	CcSEcCtD
Ramipril—Vomiting—Gemcitabine—kidney cancer	8.8e-05	0.000314	CcSEcCtD
Ramipril—Rash—Gemcitabine—kidney cancer	8.72e-05	0.000311	CcSEcCtD
Ramipril—Dermatitis—Gemcitabine—kidney cancer	8.72e-05	0.000311	CcSEcCtD
Ramipril—Headache—Gemcitabine—kidney cancer	8.67e-05	0.000309	CcSEcCtD
Ramipril—Nausea—Vincristine—kidney cancer	8.66e-05	0.000309	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.66e-05	0.000309	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—kidney cancer	8.63e-05	0.000307	CcSEcCtD
Ramipril—Insomnia—Capecitabine—kidney cancer	8.6e-05	0.000306	CcSEcCtD
Ramipril—Paraesthesia—Capecitabine—kidney cancer	8.54e-05	0.000304	CcSEcCtD
Ramipril—Hypersensitivity—Paclitaxel—kidney cancer	8.54e-05	0.000304	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—kidney cancer	8.5e-05	0.000303	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—kidney cancer	8.48e-05	0.000302	CcSEcCtD
Ramipril—Dyspnoea—Capecitabine—kidney cancer	8.48e-05	0.000302	CcSEcCtD
Ramipril—Dyspepsia—Capecitabine—kidney cancer	8.37e-05	0.000298	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—kidney cancer	8.31e-05	0.000296	CcSEcCtD
Ramipril—Asthenia—Paclitaxel—kidney cancer	8.31e-05	0.000296	CcSEcCtD
Ramipril—Decreased appetite—Capecitabine—kidney cancer	8.26e-05	0.000295	CcSEcCtD
Ramipril—Nausea—Gemcitabine—kidney cancer	8.22e-05	0.000293	CcSEcCtD
Ramipril—Gastrointestinal disorder—Capecitabine—kidney cancer	8.21e-05	0.000292	CcSEcCtD
Ramipril—Fatigue—Capecitabine—kidney cancer	8.2e-05	0.000292	CcSEcCtD
Ramipril—Pruritus—Paclitaxel—kidney cancer	8.2e-05	0.000292	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—kidney cancer	8.16e-05	0.000291	CcSEcCtD
Ramipril—Constipation—Capecitabine—kidney cancer	8.13e-05	0.00029	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—kidney cancer	8.04e-05	0.000287	CcSEcCtD
Ramipril—Flushing—Doxorubicin—kidney cancer	8.01e-05	0.000285	CcSEcCtD
Ramipril—Diarrhoea—Paclitaxel—kidney cancer	7.93e-05	0.000282	CcSEcCtD
Ramipril—Feeling abnormal—Capecitabine—kidney cancer	7.83e-05	0.000279	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—kidney cancer	7.79e-05	0.000278	CcSEcCtD
Ramipril—Gastrointestinal pain—Capecitabine—kidney cancer	7.77e-05	0.000277	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—kidney cancer	7.77e-05	0.000277	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—ACHE—kidney cancer	7.76e-05	0.00689	CbGpPWpGaD
Ramipril—Arrhythmia—Doxorubicin—kidney cancer	7.71e-05	0.000275	CcSEcCtD
Ramipril—Dizziness—Paclitaxel—kidney cancer	7.66e-05	0.000273	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—kidney cancer	7.62e-05	0.000272	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—kidney cancer	7.56e-05	0.000269	CcSEcCtD
Ramipril—Urticaria—Capecitabine—kidney cancer	7.55e-05	0.000269	CcSEcCtD
Ramipril—Abdominal pain—Capecitabine—kidney cancer	7.52e-05	0.000268	CcSEcCtD
Ramipril—Body temperature increased—Capecitabine—kidney cancer	7.52e-05	0.000268	CcSEcCtD
Ramipril—Erythema—Doxorubicin—kidney cancer	7.51e-05	0.000268	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—kidney cancer	7.51e-05	0.000268	CcSEcCtD
Ramipril—Tension—Doxorubicin—kidney cancer	7.37e-05	0.000263	CcSEcCtD
Ramipril—Vomiting—Paclitaxel—kidney cancer	7.37e-05	0.000262	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—kidney cancer	7.35e-05	0.000262	CcSEcCtD
Ramipril—Rash—Paclitaxel—kidney cancer	7.3e-05	0.00026	CcSEcCtD
Ramipril—Dermatitis—Paclitaxel—kidney cancer	7.3e-05	0.00026	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—kidney cancer	7.29e-05	0.00026	CcSEcCtD
Ramipril—Headache—Paclitaxel—kidney cancer	7.26e-05	0.000259	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—kidney cancer	7.22e-05	0.000257	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—MME—kidney cancer	7.01e-05	0.00623	CbGpPWpGaD
Ramipril—Hypersensitivity—Capecitabine—kidney cancer	7e-05	0.00025	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—kidney cancer	6.97e-05	0.000248	CcSEcCtD
Ramipril—Agitation—Doxorubicin—kidney cancer	6.9e-05	0.000246	CcSEcCtD
Ramipril—Nausea—Paclitaxel—kidney cancer	6.88e-05	0.000245	CcSEcCtD
Ramipril—Asthenia—Capecitabine—kidney cancer	6.82e-05	0.000243	CcSEcCtD
Ramipril—Malaise—Doxorubicin—kidney cancer	6.77e-05	0.000241	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—kidney cancer	6.75e-05	0.00024	CcSEcCtD
Ramipril—Syncope—Doxorubicin—kidney cancer	6.73e-05	0.00024	CcSEcCtD
Ramipril—Pruritus—Capecitabine—kidney cancer	6.73e-05	0.00024	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—kidney cancer	6.72e-05	0.00024	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—kidney cancer	6.64e-05	0.000236	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—kidney cancer	6.6e-05	0.000235	CcSEcCtD
Ramipril—Cough—Doxorubicin—kidney cancer	6.55e-05	0.000234	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—RPL14—kidney cancer	6.52e-05	0.00579	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—HSPD1—kidney cancer	6.52e-05	0.00579	CbGpPWpGaD
Ramipril—Convulsion—Doxorubicin—kidney cancer	6.51e-05	0.000232	CcSEcCtD
Ramipril—Diarrhoea—Capecitabine—kidney cancer	6.51e-05	0.000232	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—kidney cancer	6.39e-05	0.000228	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—kidney cancer	6.39e-05	0.000228	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—kidney cancer	6.39e-05	0.000228	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—kidney cancer	6.37e-05	0.000227	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.35e-05	0.000226	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—kidney cancer	6.32e-05	0.000225	CcSEcCtD
Ramipril—Dizziness—Capecitabine—kidney cancer	6.29e-05	0.000224	CcSEcCtD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.25e-05	0.00555	CbGpPWpGaD
Ramipril—Dry mouth—Doxorubicin—kidney cancer	6.25e-05	0.000223	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—kidney cancer	6.18e-05	0.00022	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—kidney cancer	6.13e-05	0.000218	CcSEcCtD
Ramipril—Oedema—Doxorubicin—kidney cancer	6.13e-05	0.000218	CcSEcCtD
Ramipril—Vomiting—Capecitabine—kidney cancer	6.04e-05	0.000215	CcSEcCtD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.04e-05	0.00536	CbGpPWpGaD
Ramipril—Shock—Doxorubicin—kidney cancer	6.03e-05	0.000215	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.02e-05	0.00535	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.02e-05	0.00535	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.02e-05	0.00535	CbGpPWpGaD
Ramipril—Nervous system disorder—Doxorubicin—kidney cancer	6.01e-05	0.000214	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—kidney cancer	6e-05	0.000214	CcSEcCtD
Ramipril—Rash—Capecitabine—kidney cancer	5.99e-05	0.000214	CcSEcCtD
Ramipril—Dermatitis—Capecitabine—kidney cancer	5.99e-05	0.000213	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—kidney cancer	5.98e-05	0.000213	CcSEcCtD
Ramipril—BCHE—Neuronal System—KCNMA1—kidney cancer	5.97e-05	0.0053	CbGpPWpGaD
Ramipril—Headache—Capecitabine—kidney cancer	5.96e-05	0.000212	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—kidney cancer	5.95e-05	0.000212	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—kidney cancer	5.92e-05	0.000211	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—kidney cancer	5.84e-05	0.000208	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.8e-05	0.00515	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—ACHE—kidney cancer	5.76e-05	0.00512	CbGpPWpGaD
Ramipril—Hypotension—Doxorubicin—kidney cancer	5.73e-05	0.000204	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—EIF5B—kidney cancer	5.7e-05	0.00506	CbGpPWpGaD
Ramipril—Nausea—Capecitabine—kidney cancer	5.65e-05	0.000201	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5.6e-05	0.00498	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.59e-05	0.00497	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.59e-05	0.00497	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.59e-05	0.00497	CbGpPWpGaD
Ramipril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.58e-05	0.000199	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—kidney cancer	5.54e-05	0.000198	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—kidney cancer	5.5e-05	0.000196	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—kidney cancer	5.46e-05	0.000195	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—kidney cancer	5.45e-05	0.000194	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—kidney cancer	5.39e-05	0.000192	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—ACHE—kidney cancer	5.38e-05	0.00478	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.38e-05	0.00478	CbGpPWpGaD
Ramipril—Decreased appetite—Doxorubicin—kidney cancer	5.33e-05	0.00019	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	5.31e-05	0.00472	CbGpPWpGaD
Ramipril—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.29e-05	0.000189	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—kidney cancer	5.28e-05	0.000188	CcSEcCtD
Ramipril—Constipation—Doxorubicin—kidney cancer	5.24e-05	0.000187	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—POMC—kidney cancer	5.15e-05	0.00457	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—PAX6—kidney cancer	5.12e-05	0.00454	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CTSD—kidney cancer	5.09e-05	0.00452	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CUL7—kidney cancer	5.08e-05	0.00451	CbGpPWpGaD
Ramipril—Feeling abnormal—Doxorubicin—kidney cancer	5.05e-05	0.00018	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—kidney cancer	5.01e-05	0.000179	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—kidney cancer	4.87e-05	0.000173	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—HSPA9—kidney cancer	4.85e-05	0.0043	CbGpPWpGaD
Ramipril—Abdominal pain—Doxorubicin—kidney cancer	4.84e-05	0.000173	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—kidney cancer	4.84e-05	0.000173	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—BCHE—kidney cancer	4.68e-05	0.00416	CbGpPWpGaD
Ramipril—Hypersensitivity—Doxorubicin—kidney cancer	4.52e-05	0.000161	CcSEcCtD
Ramipril—BCHE—Neuronal System—ACHE—kidney cancer	4.42e-05	0.00392	CbGpPWpGaD
Ramipril—Asthenia—Doxorubicin—kidney cancer	4.4e-05	0.000157	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—kidney cancer	4.34e-05	0.000155	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—kidney cancer	4.19e-05	0.000149	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—kidney cancer	4.05e-05	0.000144	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—MUC4—kidney cancer	3.95e-05	0.00351	CbGpPWpGaD
Ramipril—Vomiting—Doxorubicin—kidney cancer	3.9e-05	0.000139	CcSEcCtD
Ramipril—Rash—Doxorubicin—kidney cancer	3.86e-05	0.000138	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—kidney cancer	3.86e-05	0.000138	CcSEcCtD
Ramipril—Headache—Doxorubicin—kidney cancer	3.84e-05	0.000137	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—ST3GAL2—kidney cancer	3.76e-05	0.00334	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—CTNNB1—kidney cancer	3.67e-05	0.00326	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—EEF2—kidney cancer	3.67e-05	0.00326	CbGpPWpGaD
Ramipril—Nausea—Doxorubicin—kidney cancer	3.64e-05	0.00013	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—IGF2—kidney cancer	3.63e-05	0.00322	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACY1—kidney cancer	3.45e-05	0.00307	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.18e-05	0.00282	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.07e-05	0.00273	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.95e-05	0.00262	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.95e-05	0.00262	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PDHB—kidney cancer	2.94e-05	0.00261	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.85e-05	0.00253	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MME—kidney cancer	2.81e-05	0.0025	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CCBL1—kidney cancer	2.76e-05	0.00245	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—HSPD1—kidney cancer	2.62e-05	0.00232	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—RPL14—kidney cancer	2.62e-05	0.00232	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	2.56e-05	0.00228	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.5e-05	0.00222	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PTEN—kidney cancer	2.43e-05	0.00216	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.42e-05	0.00215	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—POMC—kidney cancer	2.42e-05	0.00215	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPAT—kidney cancer	2.39e-05	0.00213	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GLIPR1—kidney cancer	2.39e-05	0.00213	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.36e-05	0.0021	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.34e-05	0.00208	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.25e-05	0.002	CbGpPWpGaD
Ramipril—BCHE—Metabolism—APRT—kidney cancer	2.23e-05	0.00198	CbGpPWpGaD
Ramipril—BCHE—Metabolism—FH—kidney cancer	2.23e-05	0.00198	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ACHE—kidney cancer	2.16e-05	0.00192	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.14e-05	0.0019	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.13e-05	0.00189	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GPC3—kidney cancer	2.09e-05	0.00186	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PAX6—kidney cancer	2.05e-05	0.00182	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CTSD—kidney cancer	2.04e-05	0.00181	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CA2—kidney cancer	2.04e-05	0.00181	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ALAD—kidney cancer	1.98e-05	0.00176	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—BRAF—kidney cancer	1.96e-05	0.00174	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ST3GAL2—kidney cancer	1.94e-05	0.00172	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ALDH1A1—kidney cancer	1.89e-05	0.00168	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PGK1—kidney cancer	1.81e-05	0.00161	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A3—kidney cancer	1.81e-05	0.00161	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LDHB—kidney cancer	1.78e-05	0.00158	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CTNNB1—kidney cancer	1.73e-05	0.00153	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	1.71e-05	0.00152	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—RAF1—kidney cancer	1.64e-05	0.00146	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CA9—kidney cancer	1.54e-05	0.00137	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.51e-05	0.00134	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.47e-05	0.0013	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF2—kidney cancer	1.46e-05	0.00129	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.00122	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CRABP1—kidney cancer	1.31e-05	0.00117	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.27e-05	0.00113	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ITPR2—kidney cancer	1.22e-05	0.00108	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—MAPK1—kidney cancer	1.12e-05	0.000999	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.12e-05	0.000999	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACHE—kidney cancer	1.11e-05	0.000988	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTT1—kidney cancer	1.11e-05	0.000988	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SCARB1—kidney cancer	1.05e-05	0.000935	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGS1—kidney cancer	1.04e-05	0.000926	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PSMD7—kidney cancer	1.02e-05	0.000908	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—POMC—kidney cancer	9.72e-06	0.000863	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A5—kidney cancer	9.57e-06	0.00085	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC2A1—kidney cancer	9.24e-06	0.000821	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.97e-06	0.000797	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.82e-06	0.000695	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTP1—kidney cancer	7.71e-06	0.000685	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ABCB1—kidney cancer	7.3e-06	0.000648	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTM1—kidney cancer	7.08e-06	0.000629	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	6.93e-06	0.000616	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1A1—kidney cancer	6.72e-06	0.000597	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.52e-06	0.00049	CbGpPWpGaD
Ramipril—BCHE—Metabolism—POMC—kidney cancer	5.01e-06	0.000445	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGS2—kidney cancer	3.99e-06	0.000355	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTEN—kidney cancer	3.48e-06	0.000309	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CA—kidney cancer	2.46e-06	0.000218	CbGpPWpGaD
